Allogene Therapeutics (ALLO) Common Equity (2018 - 2026)
Allogene Therapeutics' Common Equity came in at $436.18 million for Q2 2026, up 26.6% from $344.56 million a year earlier and up 56.4% from the prior quarter.
Powered by 
Analysis
Allogene Therapeutics (ALLO) Common Equity (2018 - 2026) Analysis & Trends
At the end of FY2025, Allogene Therapeutics' Common Equity was $292.54 million, down 30.7% from FY2024.
- Common Equity has declined in each of the last five years, with a five-year compound annual growth rate of -22.0% (FY2020 to FY2025).
- Going back by year, Common Equity was $422.18 million in FY2024 (-17.6%), $512.23 million in FY2023 (-23.2%), $666.88 million in FY2022 (-27.9%) and $925.2 million in FY2021 (-8.7%).
- The Q2 2026 figure represents the highest quarterly Common Equity since Q3 2024.
- Year-over-year, Common Equity increased in 1 of the last eight quarters, with an average decline of 18.9%.
- The fastest year-over-year change in Common Equity over five years came in Q2 2026 (growth of 26.6%), and the weakest in Q2 2025 (a decline of 33.1%).
- Business Quant data shows ALLO's Common Equity at $278.88 million (Q1 2026), $292.54 million (Q4 2025) and $315.33 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Allogene Therapeutics | 562.91 Mn | 562.91 Mn | - | 436.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 436.18 Mn |
| Mar 31, 2026 | 278.88 Mn |
| Dec 31, 2025 | 292.54 Mn |
| Sep 30, 2025 | 315.33 Mn |
| Jun 30, 2025 | 344.56 Mn |
| Mar 31, 2025 | 385.39 Mn |
| Dec 31, 2024 | 422.18 Mn |
| Sep 30, 2024 | 463.75 Mn |
| Jun 30, 2024 | 515.04 Mn |
| Mar 31, 2024 | 461.37 Mn |
| Dec 31, 2023 | 512.23 Mn |
| Sep 30, 2023 | 580.64 Mn |
| Jun 30, 2023 | 621.41 Mn |
| Mar 31, 2023 | 592.01 Mn |
| Dec 31, 2022 | 666.88 Mn |
| Sep 30, 2022 | 743.40 Mn |
| Jun 30, 2022 | 806.48 Mn |
| Mar 31, 2022 | 865.27 Mn |
| Dec 31, 2021 | 925.20 Mn |
| Sep 30, 2021 | 969.94 Mn |
API Access
Allogene Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=ALLO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "ALLO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=ALLO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();